Gene Review:
parC - DNA topoisomerase IV subunit A
Escherichia coli O157:H7 str. EDL933
- Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli. Zhao, X., Quinn, B., Kerns, R., Drlica, K. J. Antimicrob. Chemother. (2006)
- Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. Lautenbach, E., Fishman, N.O., Metlay, J.P., Mao, X., Bilker, W.B., Tolomeo, P., Nachamkin, I. J. Infect. Dis. (2006)
- Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa. Pasquali, F., Manfreda, G. Vet. Microbiol. (2007)
- Vertical transmission of a fluoroquinolone-resistant Escherichia coli within an integrated broiler operation. Petersen, A., Christensen, J.P., Kuhnert, P., Bisgaard, M., Olsen, J.E. Vet. Microbiol. (2006)
- Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria. Vila, J., Sánchez-Céspedes, J., Sierra, J.M., Piqueras, M., Nicolás, E., Freixas, J., Giralt, E. Int. J. Antimicrob. Agents (2006)